#OP0146 explores #US biomarkers in #at-risk RA individuals: Tenosynovitis shows a HR of 2.9 to predict arthritis development - 57% of those with tenosynovitis developed arthritis vs 23% without #EULAR2021 @RheumNow https://t.co/SPkzQqQ0e5